Human papillomavirus (HPV) is the most prevalent sexually transmitted infection worldwide
and ano-genital warts (AGWs) are highly infectious. This virus is transmitted through sexual …

Objective: To review evidence on the efficacy of HPV vaccines in the prevention of non-
cancer lesions (anogenital warts [AGW], recurrent laryngeal papillomatosis and oral …

Anogenital warts (AGWs) rank among the most frequent sexually transmitted infections in
young adults. They are benign lesions, but they pose a significant economic cost to health …

Background Human papillomavirus (HPV) infections are associated with common
dermatologic and nondermatologic diseases. Although HPV vaccines are well established …

Background Human papillomavirus (HPV) vaccination is safe and effective in preventing
cervical cancer in females. As HPV infections can also induce cancers of the anus, penis …

Background Assessing the impact and effectiveness of HPV vaccines on anogenital warts in
the United States can provide early indication of the success of vaccination programs as well …

Objective: To assess evidence on the efficacy of adjuvant human papillomavirus (HPV)
vaccination in patients treated for HPV-related disease across different susceptible organ …

Anogenital and oropharyngeal infections with human papilloma viruses (HPV) are common.
Clinically manifest disease may significantly impact quality of life; the treatment of HPV …

Background We assessed the effectiveness of the quadrivalent human papillomavirus
vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital …

Human papillomavirus (HPV) vaccines are preventive measures to decrease HPV infection
rates. Knowledge of their efficacy as treatment options for anogenital warts (AGWs) and oral …